A new era of vaccines leaves old questions about prices unanswered

The world is entering a new era of vaccines. Following the success of covid-19 mRNA shots, scientists have a far greater capacity to tailor shots to a virus’s structure, putting a host of new vaccines on the horizon.

Novartis CEO: Trying to crack obesity market with another first-gen agent is ‘not a prudent approach’

Novartis doesn’t want to play the me-too game in obesity. On Thursday, CEO Vas Narasimhan said that trying to compete in the multibillion-dollar obesity market

July 19, 2024

New cardiovascular risk model could greatly decrease use of statins and increase heart attacks, study warns

If millions of Americans no longer qualify for a statin or a blood pressure medication based on a new calculator updated to better predict their

July 29, 2024

Gilead’s blockbuster ADC Trodelvy fails bladder cancer confirmatory study

Gilead on Thursday disclosed that Trodelvy, the antibody-drug conjugate that is a key part of the drugmaker’s oncology business, failed a Phase 3 study after

May 31, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.